Company / Cash & Equivalents
KORU Medical Systems, Inc. Cash & Equivalents History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$8.9M
FY2025
5-year range
$8.9M / $27.3M
FY2021-FY2025
Trend
-7.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 4 consecutive years, from $27M in FY2021 to $9M in FY2025.
Based on SEC 10-K filings.
$9M in FY2025 with a 10-year CAGR of +13.2%.
Declined from $11M to $9M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -20.1%
- 5-Year CAGR
- +8.6%
- 10-Year CAGR
- +13.2%
Key checks
Key Insights
- KORU Medical Systems, Inc.'s cash & equivalents has declined for 4 consecutive years.
- 5-year CAGR of +8.6%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 7.4% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.9M | -7.4% |
| FY2024 | $9.6M | -16.6% |
| FY2023 | $11.5M | -34.0% |
| FY2022 | $17.4M | -36.3% |
| FY2021 | $27.3M | +365.3% |
| FY2020 | $5.9M | +57.0% |
| FY2019 | $3.7M | -11.0% |
| FY2017 | $4.2M | +64.3% |
| FY2015 | $2.6M | +32.5% |
| FY2013 | $1.9M | +9.9% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026